Telomerase beats gold standard biomarkers CA 19-9, CEA, and Mayo formula-differentiates cholangiocarcinoma from benign bile ducts — It can be done with ERCP — A major clinical diagnostic advancement

✍ Scribed by Tarun Mullick; Jason Tasch; Paul Yeaton; Michel Kahaleh; Adrian Ormsby; Jeff Zaidman; Sachin Jain; R.M. Walsh; Terry L. Gramlich; John J. Vargo; Gregory Zuccaro Jr.; Darwin L. Conwell

• Book ID: 119427345
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 185 KB
• Volume: 124
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/s0016-5085(03)80487-0